[Imatinib therapy for patients with chronic myelogenous leukemia]. [electronic resource]
- Gan to kagaku ryoho. Cancer & chemotherapy Mar 2005
- 297-303 p. digital
Publication Type: English Abstract; Journal Article; Review
0385-0684
Antineoplastic Agents--therapeutic use Benzamides Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Hematopoietic Stem Cell Transplantation Humans Imatinib Mesylate Interferon-alpha--administration & dosage Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Philadelphia Chromosome Piperazines--therapeutic use Protein Kinase Inhibitors--therapeutic use Pyrimidines--therapeutic use Remission Induction